Judge keeps the lid on

WASHINGTON - U.S. District Court Judge Paul Friedman last week rejected a motion filed by Sonus Pharmaceuticals Inc. (SNUS, Bothell, Wash.) to allow FDA to schedule an advisory panel meeting for the company's EchoGen contrast agent. Friedman's action continues the current freeze on all regulatory activity related to several fluorocarbon gas bubble-based ultrasound contrast products.

Under FDA rules, the agency is supposed to reply

Read the full 640 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE